Location History:
- Thousand Oaks, CA (US) (1987)
- Los Altos, CA (US) (2018 - 2021)
Company Filing History:
2 out of 6 
1 out of 915 
2 out of 832,843 Years Active: 1987-2021
Title: Michael D Horowitz: Innovator in Targeted Therapies
Introduction
Michael D Horowitz is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of targeted therapies, holding a total of 4 patents. His work focuses on innovative approaches to combat various medical challenges.
Latest Patents
Among his latest patents is the invention titled "Anti-pre-BCR antagonists and methods." This disclosure describes the identification of pre-B Cell Receptor (pre-BCR) antagonists and their use as targeted therapy. The compositions and methods generally involve a composition that includes a pre-B cell receptor (pre-BCR) antagonist engineered for expression as a T cell chimeric receptor. In some embodiments, the pre-BCR antagonists can include an anti-pre-BCR antibody. Another significant patent is related to "Sur-binding proteins against ERBB3." This invention concerns constructs comprising surrogate light chain sequences that can bind to ErbB3 and aspects relating to such constructs.
Career Highlights
Michael has worked with various companies, including I2 Pharmaceuticals, Inc. His innovative work has positioned him as a key figure in the development of new therapeutic strategies.
Collaborations
Throughout his career, Michael has collaborated with notable individuals such as Ramesh Bhatt and Lawrence C Horowitz. These collaborations have further enhanced his contributions to the field.
Conclusion
Michael D Horowitz is a distinguished inventor whose work in targeted therapies has led to significant advancements in medical science. His patents reflect a commitment to innovation and improving patient outcomes.